Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer

Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer

Background: The effects of realgar against non-small cell lung cancer (NSCLC) have been massively studied, but the direct therapeutic targets of realgar remain unclear. This study aimed to identify the molecular targets of realgar against NSCLC and explore their therapeutic mechanisms based on a net...

Full description

Bibliographic Details
Main Authors: Rui Guo, Xiaoyu Gong, Kongzhao Li, Zhengqi Qiu, Lina Yang, Yanbin Wan, Xinhuang Yao, Canling Long, Jiqing Xu, Kang Li, Jingyan Liu, Jia Liu
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Heliyon
Subjects:
Molecular docking
Network pharmacology
Realgar
Non-small cell lung cancer
Xanthine oxidase
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022039548

Internet

http://www.sciencedirect.com/science/article/pii/S2405844022039548

Similar Items